Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Parnassus Mid Cap Growth Fund 2024 Q1 Investor Letter | Buyside Digest

Back to Fund Profile (Parnassus Mid Cap Growth Fund)

Primary Source Intelligence • Q1 2024 Letter Analysis

Parnassus Mid Cap Growth Fund Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Parnassus Mid Cap Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+7.85%

Annualized+8.83%

Digest Analysis

Quick Take

"Parnassus Mid Cap Growth underperformed in Q1 2024 due to Consumer Discretionary and Health Care stock selection, despite strong Information Technology performance."

Executive Summary

The Parnassus Mid Cap Growth Fund returned 7.85% in Q1 2024, underperforming the Russell Midcap Growth Index's 9.50% return. Stock selection in Consumer Discretionary and Health Care hampered results, while Information Technology and Financials contributed positively. Key contributors included Progressive, which posted improved underwriting profitability, and KLA Corporation, which reported better-than-expected earnings. Notable detractors included Lululemon Athletica, which issued disappointing sales guidance, and MercadoLibre, which reported lower-than-expected margins. The portfolio remains overweight in Information Technology, Consumer Discretionary, and shifted to an overweight in Financials. The managers maintain exposure to software, semiconductors, and life sciences tools, believing in secular growth opportunities. They added positions in PTC and Atlassian while exiting Lam Research due to valuation concerns. The Fund maintains a balanced stance amid rising valuations, focusing on high-quality growth compounders that can provide upside participation with downside protection. The managers expect mid-cap growth valuations to return to historical premiums over large-cap growth, especially if inflation continues to decelerate and rate cuts limit economic pressure.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

The Fund runs a concentrated portfolio of 35-45 positions with clear overweight themes in software, semiconductors, and life sciences tools. Managers provide specific rationale for individual holdings and sizing decisions, though some hedging language around market conditions prevents a higher score.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The managers express cautious optimism about economic resilience, inflation deceleration, and planned Fed rate cuts, but acknowledge rising valuations and note that markets rarely go straight up. The tone is constructive but balanced with risk awareness.

Risk Appetite

0%

DefensiveAggressive

Defensive (0%)

The portfolio maintains a balanced stance with overweight positions in select themes but explicitly states this balance is due to rising valuations offsetting improving economic outlook. No clear directional bias toward increased or decreased risk.

Capital Deployment

15%

De-riskingDeploying

De-risking (15%)

The Fund added two new positions (PTC, Atlassian) and exited three positions (Lam Research, Ball Corp, Ansys/Synopsys), representing modest net rotation activity. No cash level changes mentioned, suggesting limited net deployment.

Forward Guidance

10%

CautiousExpansionary

Cautious (10%)

The managers are selectively adding positions (PTC, Atlassian) and maintaining overweight exposures in preferred themes, but emphasize balance and patience rather than aggressive deployment. Mild positive bias but cautious approach.

Language Signal

15%

BearishBullish

Bearish (15%)

Language includes positive terms like opportunities, attractive valuations, secular growth, and robust demand, but is balanced with risk language about rising valuations, market corrections, and the need for selectivity.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

Managers acknowledge standard market risks including rising valuations, inflation concerns, and the magnitude of the recent rally. Risk discussion is present but not central to the letter, focusing more on opportunities than threats.

Opportunity Density

65%

ScarceAbundant

Abundant (65%)

The managers identify multiple attractive themes including software, semiconductors, and life sciences tools, and successfully added new positions. They describe finding opportunities despite rising valuations, suggesting a moderately rich opportunity set.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

The Fund explicitly pursues long-term outperformance with focus on secular growth themes and multi-year thesis development. Managers discuss holding through short-term volatility and expect multi-year value realization for themes like life sciences tools recovery.